Conference Coverage

Rivaroxaban bonus: Early unmasking of occult GI cancers

Publish date: September 22, 2018

 

REPORTING FROM THE ESC CONGRESS 2018

Pages

Recommended Reading

New look at ATLAS suggests rivaroxaban may still have role in ACS
MDedge Family Medicine
DOJ lawsuit reins in inappropriate ICD use
MDedge Family Medicine
DOACs’ safety affirmed in real-world setting
MDedge Family Medicine
DOACs found safer than warfarin in the real world
MDedge Family Medicine
Guideline: PFO closure best bet for recurrent stroke prevention
MDedge Family Medicine
Blood pressure control prevents cognitive impairment
MDedge Family Medicine
A new, simple, inexpensive DVT diagnostic aid
MDedge Family Medicine
VTE risk unchanged by rivaroxaban after discharge
MDedge Family Medicine
New stroke intervention guidelines stress volume
MDedge Family Medicine
Expert panel updates guidelines on antithrombotic therapy for AF
MDedge Family Medicine